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ABSTRACT 
 
Lack of a viable vascular network impedes 3D bioprinting from creating functional tissues. Utilizing the 
native vasculature of decellularized spinach leaves as a scaffold for cell seeding provides the potential to 
form a viable vascular network. This network coupled with a gel matrix has the potential to provide the 
support and nutrients necessary for printing functioning tissues. Our data shows cell viability within a 
seeded scaffold after 36 hours and demonstrates cellular escape from the spinach leaf scaffold. When 
combined, the data shows that cells have the ability to adhere and escape from the scaffold, into a gel matrix, 
mimicking the initial steps for vascular growth.  
ii 
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I. INTRODUCTION 
very year, over 116 thousand people are in 
dire need of a transplant and every ten 
minutes, someone is added to a transplant 
waiting list. Roughly 50% of the patients in need 
of a transplant are under the age of 49, as 
presented in Figure 1. This need, coupled with the 
average lifespan in the United States of 
approximately 79 years, stresses the need for long 
term solutions to organ replacements. However, 
with only 12 thousand organ donors, many of the 
needed transplants cannot be performed. Many 
transplants involve major organs such as the 
kidney, liver, heart, and lungs, and even with 
adequate organ donor supply, there are many 
criteria that need to be met to ensure a donor 
organ will be compatible with the recipient. These 
criteria include, but are not limited to, blood type, 
organ type and size, and patient physiology. 
These and other factors greatly reduce the 
number of successful transplants [1]. 
 
Figure 1: Ages of patients receiving transplants last year [1]  
Although organs can sometimes be retrieved 
within the short time following the death of a 
patient, there is a short time frame for organ 
viability. This time frame ranges from 24-36 
hours in kidneys to 4-6 hours in heart and lung 
tissue. This adds yet another variable, 
complicating the organ transplant process and 
lessening the possibility of a successful transplant 
[1]. 
Tissue engineering aims to alleviate this 
problem by developing functioning in vitro 
tissues via three-dimensional (3D) bioprinting. 
Currently, the designated cell types for the 
intended tissue or organ are being printed into 
supportive gel matrices. The gel acts as a 
supportive environment with physical 
characteristics similar to those found within the 
human body. However, one of the major 
obstacles with this process is vascularization and 
the diffusion of nutrients. While the gel provides 
the proper structural support, cells and nutrients 
cannot be adequately delivered through the 
matrix, resulting in cell death. Vascularization is 
critical because it provides an oxygen-rich 
environment for the diffusion of nutrients, 
similar to that found naturally in human tissue. 
Without proper diffusion of nutrients through 
tissue engineering matrices, the newly seeded 
cells do not survive long enough to differentiate 
into functioning tissues [2] [3]. Therefore, there 
is a need for a functioning vascular network to 
support cell growth, survival, and development 
within the contexts of 3D bioprinting of new 
tissues and organs. 
The project aims to establish a network to 
mimic vasculature in the body and improve 
oxygen and nutrient diffusion to the cells being 
printed. The system will utilize existing vascular 
networks found naturally in other tissues as a 
structural base. Tissue engineers have tried to 
address this issue in the past using 
decellularization. Through this, the cells that 
make up a tissue, defining its biological 
properties, are washed away, leaving behind only 
the structural components of the tissue. 
Traditionally, this process has been performed on 
organs to allow for the possibility to seed new 
cells and provide non-specific donor organs [4]. 
Although this application would widen the donor 
pool, it still relies on the availability of organ 
donors for tissues. 
An alternative example of such a system is 
using the existing vasculature of decellularized 
plant materials. Two potential plant scaffolds for 
this application include decellularized spinach 
leaves and decellularized parsley stems. Spinach 
leaves have a main stem and a small, intricate 
system of vasculature that is similar to that of 
human veins, while parsley stems provide a 
simple, more robust, one-dimensional scaffold. 
In order to utilize these materials, the plants need 
to be decellularized, removing the cells that 
biologically define the plant, leaving only those 
necessary for structure. With only the 
extracellular, or structural, components 
remaining, the plant structure now serves as a 
E 
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possible scaffold for seeding human cells [5]. In 
the body, new vasculature is formed by a process 
known as angiogenesis. During this process, new 
vessels sprout from the original vessel to create a 
more intricate network [6]. By utilizing the 
scaffold of the plant material and angiogenic 
signaling pathways, this project aims to establish 
a larger, viable network. 
Feasibility studies were performed to 
determine which potential scaffold would be 
more suitable for inducing these angiogenic 
pathways. The first step necessary for sprouting 
new blood vessels is the adequate adhesion of 
human cells to the chosen plant scaffold. Because 
of the large surface to volume ratio of the parsley 
stems, the data showed inadequate adhesion of 
the human cells to the plant stem. This, along 
with the published success of seeding human cells 
into decellularized spinach leaves led the team to 
ultimately move forward with decellularized 
spinach leaves as the scaffold for inducing 
angiogenesis. Adequate adhesion of human cells 
to the spinach leaves, in addition to proper 
cellular escape from the leaf vasculature into the 
gel matrix, would promote the growth of new 
blood vessels and eventually lead to the 
development of a vascular network within the gel 
matrix used for 3D printing. This would allow for 
the diffusion of oxygen to the cells being printed 
into the gel matrix, eventually promoting the 
growth of new tissues and reducing the overall 
need for organ transplants.  
II. LITERATURE REVIEW 
eople get sick or injured every day, leaving 
organs and tissues in high demand without a 
reliable means to meet that need. According to 
the United Network for Organ Sharing (UNOS), 
someone is added to the national transplant 
waiting list every ten minutes, and an average of 
20 people die each day waiting for transplants [1]. 
Tissue engineering and regenerative medicine 
have begun various initiatives to engineer tissues 
and organs that would be both biocompatible and 
functional in the body, thus reducing the pressing 
and unattainable need for organ transplants [2].  
A. Regenerative Medicine 
The field of regenerative medicine covers a 
broad range of topics and is looked at as a highly 
interdisciplinary field of study encompassing past 
surgeries, hospital procedures, and the overall 
advancement of biological scaffolds [3]. Its 
primary focus is aimed at replacing or 
regenerating human cells, tissues, or organs to 
fully functioning use, through in vivo or ex vivo 
methods [7]. This is accomplished through the 
integration of human cell therapies, gene-based 
methods, biomaterials, and molecular medicines 
[3]. 
Stem cells offer a large potential for the field 
of regenerative medicine. Stem cells are 
undifferentiated cells with the potential to 
differentiate or specialize [8]. Adult stem cells are 
present in different tissues in the body and tend 
to differentiate into organ-specific cells; however, 
there is less potential for adult stem cells to 
mature because they are further along the 
“differentiation” path. In the clinical setting, 
these cells have been isolated and implanted back 
into patients as a method for tissue repair [9]. The 
ability to isolate cells has been coupled with 
biomaterials in an attempt to restore organ 
function [3]. 
In 1988, fetal and adult rat and mouse 
hepatocytes, pancreatic islet, and small intestine 
cells were isolated and seeded onto a synthetic 
scaffold. The scaffold contained an intertwined, 
branching network of polymers which allowed for 
vascularization and diffusion to aid in cell 
survival. Isolated clinical trials have 
demonstrated successful implantation of these 
scaffolds into mice, indicating a potential for the 
use of engineered vasculature in biomaterials [7]. 
Biomaterials are multifaceted in their 
contribution towards regeneration. For example, 
the implanted biomaterial can induce a cellular 
response allowing the patient’s cells to interact 
with the scaffold without first seeding cells ex 
vivo. Additionally, biomaterials can be used as a 
vehicle for the transport of cells and medication 
when implanted [9]. In one study, seven patients 
with myelomeningocele, a disorder resulting in 
poor bladder compliance, received artificial 
bladder scaffolds to repair the damage. The 
scaffolds were created from either collagen, or a 
mix of collagen and polyglycolic acid. Biopsies 
were taken from individual patients and their 
cells were cultured, seeded onto artificial 
scaffolds, and re-implanted into the patients. 
Postoperatively, bladder function was improved 
with an average follow-up time of 46 months, 
resulting in reduced bladder pressure and 
increased liquid capacity [10].  
P 
3 
 
When selecting biomaterials for regenerative 
medicine, it is important to consider features 
such as biocompatibility, biodegradability, 
defined shape/size, the ability to perfuse oxygen 
and nutrients, and the ability to remove waste. 
Additionally, each level of degraded polymer 
should be nontoxic, and a defined breakdown 
time should be established [11]. Two crucial 
aspects of biomaterials that incur the biggest 
problems are vascularization and the ability to 
maintain stress and strain. Other challenges to 
biomaterial use involve maximizing cell 
attachment, proliferation and differentiation on 
said material, reducing long term karyotype 
changes, and overcoming the immune response 
of the body [9]. In addition to biomaterials, the 
use of donated organs has also been presented as 
a potential scaffold for seeding cells and 
providing an organ replacement. 
Donated human organs provide a good 
structural scaffold after being decellularized. 
Once the organs are decellularized, cells can be 
re-seeded. These organs provide biochemical and 
mechanical guidance for cells to adhere, 
proliferate, and differentiate [4]. Prior to 
implantation, the organs need to be primed to 
adapt to the microenvironment of the body. 
Alexis Carrel, the father of modern cardiovascular 
and transplant surgery, provided the basis of 
regenerative medicine, collaborating with 
Charles Lindbergh to create a perfusion pump, 
allowing organs to survive outside of the body. 
This was a big step towards the bioreactors and 
perfusion systems used today[7].  
There are several advantages to using 
harvested organs as replacements. As previously 
mentioned, the organ structure can stimulate cell 
behavior, attachment, replication, and 
differentiation. There is very little immune 
response because the extracellular matrix, which 
provides structural support for cells and 
mechanical cues for cell differentiation, is similar 
amongst a species [4] [12]. The decellularized 
organs are apt to structurally change and adapt to 
in vivo conditions. The vasculature is maintained 
in these organs, combatting a big problem faced 
with biomaterial constructs [4]. However, the 
production of such organs requires a vast amount 
of time and resources and the application is still 
far from commercialization. 
B. Bioprinting 
Despite the potential of decellularization, the 
ability to use donor organs as a scaffold for a 
patient’s cells still relies on the availability of 
organs. Another option that has been recently 
explored is the possibility to grow, or more 
specifically, print biological organs for patient 
transplants. In the past, scientists have achieved 
three-dimensional (3D) fabrication through 
methods such as electrospinning, freeze-drying, 
and particle leaching; however, these methods 
create a large bulk product lacking the necessary 
precision for the development of micro-scale 
structures. Seeded scaffolds present the 
opportunity for more precise cell placement, but 
these structures take considerable amounts of 
time and money to construct [13]. In recent years, 
there has been interest in the application of 
additive manufacturing for tissue engineering. 
Use of such technology would allow for precise 
cell placement, as well as faster processing, 
providing a reliable source for engineered organs 
and tissue [14]. 
1. Classes of Bioprinters 
There are three different classes of 
bioprinters currently available; these classes, 
depicted in Figure 2, include inkjet (a), extrusion-
based (b), and light-assisted (c,d) [14]. Each 
printer has different considerations for the 
application of printing cells. Inkjet and extrusion-
based printers have been explored for the 
biofabrication of complex heterogeneous 
structures. Both printers build structures by layer 
and have the potential to disperse different cell 
types utilizing multiple nozzle attachments. The 
main difference between the two types is their 
printing surface: inkjet printers print on top of a 
multiaxial surface, while extrusion-based 
printers print inside a hydrogel [13] [15]. Light-
assisted bioprinting functions a little differently; 
it includes two major subclasses of printers: DLP 
(digital light processing)-based printers and 
laser-based printers. DLP-based printers utilize a 
digital micrometer to project UV light into a 
pattern, while laser-based printers transfer cells 
from one slide to another through a medium via 
evaporative gas pressure [13] [15]. 
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Two overarching obstacles with bioprinting 
cells and organs are the time for natural cell 
growth and the development of a vascular 
network [13][15]. Without a reasonable growth 
time, substituting engineered organs for a 
transplant is not a major improvement; without a 
viable vascular network, cells cannot gain the 
oxygen and nutrients needed for growth and 
survival [16]. 
C. Materials 
Biomaterials have been explored as a 
potential medium for the delivery of cells or 
regeneration of afflicted organs and tissues. As 
the field of regenerative medicine advances, a 
growing array of polymers and cell attractive 
materials have been explored for use in both 3D 
printing and scaffolds. Polymers may be 
formulated to provide a stable matrix for printing 
live cells for tissue production. Cell adhesive 
materials and chemoattractants can be used to 
prompt cell movement in order to sustain cell 
growth and vascular activity within these 
polymers. After obtaining cell viability and 
movement within a polymer matrix, 
vasculogenesis can begin. The sections below 
detail several materials that can be used in 
combination to contribute to the development of 
this vascular network. 
1. Matrix Materials for Cell Printing  
Hydrogels are a potential medium to provide 
a support system for cell viability and movement 
for the development of artificial organs and 
tissues. Hydrogels are unique because of their 
mechanical properties. Their properties allow for 
cell growth and expansion without mechanical 
stress buildup. The strength of the materials is 
typically dependent on gel formation - either via 
natural gelation or crosslinking. [17] Rheological 
data suggest that hydrogels can be formulated at 
varying concentrations depending on the 
intended cellular applications [17]. The flexible 
mechanical properties allow diffusion of 
nutrients, small molecules, and proteins, which is 
necessary for cell survival within a matrix [18]. 
The flow curve, measuring shear rate versus shear 
stress, is a hysteresis loop [19]. Several polymers 
detailed in Table 1 have been researched and/or 
used to promote cell viability in regenerative 
medicine. Alginate is a natural anionic polymer 
extracted from brown seaweed and has been 
found in many commercial biomedical 
applications. Due to anionic nature, alginate 
must be cross-linked with cations (typically 
Ca2+) in order to form structurally sound 
hydrogels [19]. Alginate is a hydrophilic material 
with variable mechanical properties. Naturally 
occurring alginate has a molecular weight that 
ranges from 32,000 to 400,000g/mol [19]. While 
increasing the molecular weight of alginate 
improves the polymer’s mechanical properties, 
high molecular weight alginate becomes 
extremely viscous, which is not an ideal quality 
for a cell-printing matrix. Alginate is a highly 
desired material for biomedical applications 
because it is structurally similar to the 
extracellular matrix cells are familiar with, along 
with its biocompatible tendencies. Alginate has 
been used for cell encapsulation experiments for 
tissue engineering research, and its 
biocompatible properties have shown to reduce 
the body’s immune response to the foreign body 
[19]. Various peptides such as RGD can be added 
as side chains to the alginate backbone to further 
increase biocompatible properties and induce cell 
adhesive behavior. Alginate has been in a variety 
of applications including wound healing, tissue 
engineering, and drug delivery. Although alginate 
is extremely biocompatible and is capable of easy 
gelation, the polymer is inherent nondegradable 
in mammals, 
 
Figure 2: Available 3D printing techniques [14] 
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Table 1: Properties of Cell Matrix Materials 
thus, limiting its productivity in mammalian 
tissue engineering [20]. 
Fibrin is a protein polymer that exhibits both 
viscous and elastic material properties. Despite 
its relatively low protein content, fibrin has a high 
stability in addition to a very high level of 
elasticity [21]. In addition to its role in 
thrombosis, fibrin assists in determining the 
functionality of cellular processes such as 
adhesion, migration, proliferation, 
differentiation, angiogenesis, inflammation, etc. 
[21]. Fibrin exhibits strong cell adhesive 
properties as a result of its role in blood clot 
formation and functionalizing cell processes 
within the body. Thus, theoretically, fibrin in the 
form of a gel would allow for cell adhesion upon 
seeding, as well as cell movement and nutrient 
diffusion. 
Gelatin is a natural protein obtained from the 
hydrolysis of collagen molecules. To enhance the 
properties of gelatin, cross-linking with calcium 
phosphates allows for increased mechanical 
stability. The natural mechanical properties of 
gelatin resemble those of the extracellular matrix 
and collagen fibers, thus contributing to an ideal 
cell printing environment. Recent studies have 
also shown that combining gelatin with 
polyaniline or other carbon-based substrates can 
induce conductive properties within the gelatin 
matrix for specialized cardiac and nerve tissue 
engineering [22]. Gelatin is biocompatible and 
has been shown to induce minimal immune 
responses inside the body. With cross-linking, 
gelatin can achieve bioactive properties as 
described above. Proteins such as RGD can be 
bound to the gelatin molecules to promote cell 
adhesion in tissue engineering applications. Due 
to its wide range of properties, gelatin has been 
used in a variety of biomedical applications 
including tissue engineering, 3D cell scaffolds, 
and electrospun nanofibers and nanoparticles 
[22]. While the success of gelatin is owed in large 
part to the natural properties of collagen, gelatin 
itself exhibits better solubility and antigenicity 
than collagen, leading to a promising 
environment for 3D cell printing. 
 Hyaluronic acid (HA) is a glycosaminoglycan 
copolymer naturally found in connective tissues 
such as synovial fluid at body joints and natural 
scaffolding within cartilage. As a result of its 
natural applications within the body, hyaluronic 
acid is naturally viscous and has very poor 
mechanical properties. Natural hyaluronic acid 
also has a high rate of degradation, limiting its 
function during in vivo testing. Studies have 
shown that crosslinking hyaluronic acid and 
modifying the carboxylic acid and/or alcohol 
groups of the HA backbone can improve the 
mechanical limitations of the material [23]. HA 
has shown improved cell adhesion by 
incorporating RGD as a binding peptide to the 
molecule’s chemical sequence. Because 
hyaluronic acid is found naturally throughout the 
body, it has been known to significantly 
contribute to cell proliferation and migration. 
With the proper chemical crosslinking and 
protein additives, hyaluronic acid can be a 
promising material for cell adhesion and growth. 
Material Mechanical Properties Cell Adhesion Natural vs. Synthetic 
Alginate [20] [19]  Viscosity increases as pH 
decreases; physical 
properties increase with 
MW; structure resembles 
ECM 
Yes, with the help of 
proteins (RGD) 
Natural, can be 
synthetically modified 
with surface proteins 
Fibrin Gel [21]  Very high elasticity, high 
stability, relatively low 
protein content, stiffening 
occurs in response to 
shear/ tension/ 
compression 
Yes Natural 
Gelatin [22]  Properties resemble ECM; 
crosslinking; structure 
resembles collagen 
Yes Natural, derived from 
collagen hydrolysis 
Hyaluronic Acid [18]  viscous; poor mechanical 
properties 
Yes Natural, in connective, 
epithelial & neural tissue 
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2. Cell Adhesion 
In addition to the matrix material in which 
the cells are seeded, the other vital materials are 
those that induce cell adhesion. These materials 
may be chemically combined with a matrix 
material to promote cell adhesion within the 
matrix, or they may also be printed within the 
matrix to promote cell adhesion followed by cell 
proliferation along the new material. Several 
materials commonly used for cell adhesion are 
listed in Table 2 and further detailed.  
Fibronectin is a glycoprotein that occurs in 
two different forms: soluble and insoluble. 
Soluble fibronectin is found naturally in the blood 
and body fluids, while insoluble fibronectin is 
naturally found in various connective tissues and 
is associated with basement membranes of tissue 
layers [23]. Because of its varying forms and 
functions, fibronectin has a variety of mechanical 
properties that are promising for cell adhesion 
applications in regenerative medicine. As 
detailed in Table 2, fibronectin has a molecular 
weight around 440kDa and a coefficient of 
friction around 1.7 [23]. Fibronectin yields 
extremely promising cell adhesion properties, 
and it has been proven successful in cell adhesion, 
growth, migration, and differentiation, along 
with wound healing and embryonic development 
applications. In the body’s natural environment, 
fibronectin binds to integrin proteins along cell 
membranes, and it works to bind the components 
of the extracellular matrix (including collagen 
and fibrin). If kept in its soluble form, fibronectin 
would potentially combine with a matrix material 
to promote cell adhesion to the matrix; if kept in 
its insoluble form, fibronectin would provide a 
sub-matrix for cell adhesion, growth, and 
proliferation within the printing matrix. 
 In addition to its gel form, fibrin can also be 
formulated into single-strand fibers. The proper 
extrusion of specified concentrations of 
fibrinogen and thrombin result in the formation 
of these fibers. Due to the viscoelasticity of fibrin, 
its fibers can be considered “self-repairing”; the 
fibers grow stiffer in response to shear stress, 
tension, and/or compression [21]. Fibrin exhibits 
strong cell adhesive properties because of its role 
in blood clot formation and functionalizing cell 
processes within the body [21]. Fibrin fibers have 
the potential to be printed within a matrix 
material to provide a cell adhesive material to 
promote cell growth and proliferation along a 
sub-matrix. 
Collagen is a protein that is widely 
distributed throughout all connective tissue in 
the body and thus is considered the primary 
structural protein of the extracellular matrix. 
There are 29 types of collagen, but most 
biomedical applications highlight Types I, II, III, 
V, and XI. Each type is found in different part of 
the body, and these five types are known to form 
collagen fibers [25]. Because of its role in the 
human body, collagen is extremely biocompatible 
and exhibits promising cell adhesive properties. 
In addition, collagen can be used to increase 
adhesion of various proteins, such as VEGF, for 
use in cellular applications. Type I collagen is 
successful in tissue engineering applications [25]. 
Utilizing collagen’s natural tendency to form 
fibers may be useful for printing a cell adhesive, 
collagen sub-matrix within a matrix material. 
3. Chemoattractants 
The use of various matrix materials for cell 
growth and cell adhesive materials allow for 
sufficient cellular seeding on or within 
biomaterials. In addition to these materials, 
chemoattractants may be used to promote the 
sprouting of vessels from biomaterials in tissue 
engineering applications. Vessel sprouting is 
essential for creating a vascularized network 
within matrices. Chemoattractants, or growth 
factors, can be useful in guiding cellular growth 
and movement. This can help to move cells within 
a matrix by attracting them in specified 
directions. Table 3 details several growth factors 
that can be used in promoting angiogenesis in 
various tissue engineering applications.  
D. Vasculature 
As discussed previously, when producing 
alternative tissues and organs, the largest issue is 
providing nutrients and oxygen to the cells and 
tissues. That is, the lack of a stable vascular 
network hinders the growth of healthy tissues. 
Viable vasculature must be within 200μm or less 
from all cells, act as a selective barrier, and 
minimize pressure of blood flow [32]. 
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Table 2: Properties of Cell Adhesion Materials 
 
One method to provide nutrients to 
engineered organs is achieved using a bioreactor 
to allow for vessel growth and development, but 
this often takes days or weeks, and many times 
the vasculature still will not reach the center of 
the organ. Bioprinting vascular networks was 
another option explored to help provide nutrients 
and oxygen to cells in a timely manner; however, 
the resolution of commercially available 
bioprinters is not small enough to create a dense 
enough microvascular network [33] [34] [35]. 
Studies have also explored scaffolds and 
channels built to act as vasculature, but these 
were often too dense and impermeable, or would 
shift after implantation due to vascular 
remodeling [5]. 
Methods to stimulate angiogenesis and 
induce vascularization in tissue engineered 
organs through natural pathways could allow for 
the development of smaller, more stable 
vasculature. By utilizing angiogenic pathways to 
grow a vascular network, this could potentially 
create a network that cells could be seeded or 
printed into, acting as a predeveloped, nutrient 
rich cellular scaffold [33] [34] [35].  
1. Angiogenesis and Endothelial Activity in 
Vascular Growth  
Angiogenesis is defined as the formation of 
new blood vessels from existing networks; this 
process can be spontaneous or induced by 
pathways within the cell [6]. Angiogenesis 
contains 4 key steps: the degradation of the ECM,  
  
migration of cells from the original vessel 
towards a nonvascularized region, the 
proliferation of cells, and the maturation of those 
cells [36]. For this to occur, endothelial cells, 
which line blood vessel walls, must squeeze out 
through the degraded ECM, and escape from the 
original vessel. There are two main ways in which 
this happens: angiogenic sprouting, which 
sprouts new vessels from existing vasculature, 
and intussusceptive angiogenesis, which inserts a 
pillar into existing capillaries, and branches them 
internally [37]. One important consideration for 
the information provided about angiogenesis is 
that the details of sprouting mechanisms are well 
understood while intussusceptive mechanisms 
are not. The formation of a new vessel sprout 
occurs in response to invasion of endothelial cells 
at a distinct site in the surrounding tissue or 
matrix. This process of choosing a distinct 
sprouting site repeats as the new sprout branches 
and forms a network with other surrounding 
sprouts [28]. The branching occurs by elongation 
of the sprouts, which is prompted by the 
proliferation and migration of endothelial cells. 
The repeated sprouting and elongation through 
cell growth and proliferation results in branched 
vasculature [38]. The newly created networks 
provide structure for oxygen and nutrient 
diffusion through the desired tissue vasculature. 
 
 
 
 
 
Material Mechanical Properties Cell Adhesion Natural vs. Synthetic 
Fibronectin [23]  MW ~440kDa, coefficient of 
friction ~1.7 
Yes 
(cell adhesion, growth, 
migration, 
differentiation, wound 
healing, embryonic 
development) 
Natural 
Fibrin [21]  Very high elasticity, high 
stability, relatively low protein 
content, stiffening occurs in 
response to shear/ tension/ 
compression 
Yes Natural 
RGD Peptide [24]  Principal integrin-binding 
component in ECM proteins 
Yes Natural or Synthetic 
Collagen [25]  High tensile strength Yes Natural 
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Table 3: Key Chemoattractants in Angiogenic Signaling 
  
2. Chemoattractants and Angiogenesis 
As discussed previously, chemoattractants 
can be leveraged as a means to promote vessel 
sprouting and endothelial cell migration. These 
activation pathways naturally exist in the cell as 
the body secretes factors to signal for vessel 
growth into a new region. The main pathways 
involved with angiogenesis are signaled by 
proteins such as vascular endothelial growth 
factors (VEGF), fibroblast growth factor (FGF-2), 
and platelet-derived growth factors (PDGF), as 
outlined in Table 3 [39] , the most prominent 
being VEGF. Mechanisms for sprouting are well 
known; Figure 3 depicts the varying stages of 
vessel sprouting in response to VEGF and 
endothelial cell activity. 
 
 
Figure 3: Stages of Vessel Sprouting in Response to VEGF 
and Endothelial Activity [40]  
 
 
 
 
 
 
 
 
 
 
These pathways can be targeted to help 
induce angiogenesis; for example, VEGF can be 
used as a guide for remodeling. When these are 
added to the hydrogel, the vascularization will 
follow the path of the factor [34]. Several 
experiments have shown the influential role 
VEGF plays in cellular movement and 
angiogenesis. For cellular movement, scientists 
have seeded cells in a transwell insert, and coated 
the bottom of the plate with VEGF and other 
ligands. By doing this, they can measure the 
number of cells that pass through the transwell 
membrane and compare those results to 
uncoated plates to see increased rates of cell 
migration. Similarly, to measure angiogenic 
sprouting, cells were seeded on beads and placed 
in fibrin gel which was supplemented with VEGF 
and several other ligands. The added VEGF 
resulted in increased sprout length and number 
of sprouts [41].  
Studies exploring the combination of various 
signal pathways have shown promising results 
[34]. The combination of different factors may 
help to increase the rate a vessel reaches 
maturation [33]. A study, represented in Figure 
4, targeted pathways with VEGF and angiopoietin 
1 (ANG-1) to increase the growth and maturity of 
the vascular structure at an increased rate. Over 
time, the number of cells attached to each vessel 
tip increased, but the cells that incorporated both 
growth factors had significantly more than the 
other groups, suggesting that this may speed up 
development [34].  
Material Natural or Synthetic Function 
FGF-2 [26]  Natural Maturation of fibroblast vessels 
PDGF [27]  Natural Fibroblast growth, vessel wall maturation 
VEGF [28]  Natural Endothelial cell growth, migration 
ANG – 1 [29]  Natural Stabilizes vessels during linear growth 
Nell – 1 [30]  Natural Enhance pericyte proliferative, osteogenic, and angiogenic 
capabilities 
CCN2 [31]  Natural Pro-angiogenic functions during development, would, repair, 
cancer. Direct regulator of endothelial cell activities 
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Similarly, platelet-derived growth factors 
(PDGF) andANG-1 can be used in concert to 
achieve similar results to those seen when using 
VEGF alone. In a study performed on the PDGF 
signaling pathway, platelet-derived 
microparticles were added to an existing 
vasculature. The addition of these factors greatly 
induced angiogenesis and was comparable to 
traditional VEGF factors [33]. Figures 5-2, 5-3, 5-
4, and 5-5 demonstrate the growth of the 
vasculature over time. Figure 5-6 demonstrates 
growth using VEGF factors, and Figure 5-1 
demonstrates growth without inducing 
angiogenesis. The results of this study suggest 
that various pathways can be explored to promote 
the growth and angiogenic response of 
endothelial cells.  
 
 
Figure 5: Growth of vasculature over time with PDGF 
pathway [33]  
3. Creating Leaky Vasculature in Vessels 
As discussed previously, cells need to be able 
to escape and migrate to allow for new vessel 
formation. Angiogenic sprouting requires 
increased porosity in the walls of preexisting 
vasculature; under the normal mechanisms of 
VEGF growth factors, porosity is first increased, 
by breaking down the ECM, then angiogenesis 
can occur. Without the natural breakdown of the 
ECM, the vasculature needs to be made more 
porous to ensure escape is possible [42]. A couple 
of methods to increase porosity in cell walls by 
degrading different concentrations of the present 
cellulose have been explored in previous studies. 
These methods include the use of different alkali 
treatments and cellulase digestion [43]. 
One study compared an alkali, or basic 
treatment, to treatments with acid and hot water 
solutions. In this study, leaves of the species 
Populus (trees in the Salicaceae family) were 
tested; the porosity of each leaf was measured 
following each treatment. The study found that 
treatment with hot water and dilute acid 
decreased porosity with increased temperatures 
over time, while treatment with basic solutions 
increased porosity with increased temperatures 
over time [43]. In a similar study, the effects of 
different alkali solutions on porosity were tested. 
The study analyzed four different dilute acids: 
K2CO3, Na2CO3, KOH, and NaOH. In this study 
cellulose was boiled in 0.1M of each solution, and 
it was found that the bases created varying ranges 
of porosity. The porosity each base, from the most 
porous to the least, is as follows: K2CO3 > 
Na2CO3 > KOH > NaOH [44]. 
Another option to break down the cell wall is 
to use cellulase as a catalyst for digestion. 
Cellulase cuts the polysaccharide chain of sugars 
in cellulose (one of the main components in plant 
cell walls) into individual monosaccharides, 
breaking down the structure of the plant’s cell 
wall. Cellulose is organized into long chains that 
make up microfibrils, depicted in Figure 6. The 
hydrophobic regions indicated by the arrows are 
thought to be the point for cellulase attack. This 
however, is done at random, and due to variations 
in different regions of the wall, is not always the 
most efficient way to evenly break down cellulose. 
These enzymes contain glucanases, which help to 
cleave the bonds on the cellulase chain and allow 
for hydrolysis to occur [45]. 
 
Figure 4: Effect of Targeted VEGF and ANG-1 Pathways on 
Growth and Maturity [34] 
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Many studies have been done to improve the 
digestion of cellulose. Pretreatment to the 
biomass may make the cellulose more accessible 
to the enzymes and allow for a more even 
breakdown of the cell wall. In one study, porosity 
was increased utilizing cellulase, a digestive 
enzyme, to digest portions of the cellulose in the 
cell wall. In this study, performed on corn stalk 
cell walls, the plants were pretreated with 2% 
H2SO4 and then digested with cellulase enzymes. 
The study found that the pretreatment increased 
cellulase activity, therefore increasing porosity. 
Additionally, with increased temperatures, the 
enzyme activity increased, creating relatively 
more porous cell walls [46]. Other studies have 
explored other pretreatments such as alkaline 
chemicals, and organosolvents that break down 
the other components of the cell wall, but acidic 
treatments are the only ones to reduce conversion 
time from the untreated stem and thought to 
increase accessibility of cellulose [47]. 
 
4. Leaf Anatomy: Commonalities between plant & 
animal kingdoms 
 As discussed above, the current method of 
using decellularized organs has proven successful 
only in isolated instances. One of the main 
problems with this method, however, lies in the 
availability of the necessary organs to 
decellularize and use in patients. The current 
demand for organs gravely outnumbers the 
supply available for medical use. It is nearly 
impossible to account for more than 100,000 
patients in need of transplanted organs or related 
structures [1]. The field of regenerative medicine 
is moving quickly in the direction of developing 
tissue engineered systems to provide a more 
reliable solution for obtaining viable organs. 
These systems would soften the urgent timeline 
necessary for harvesting and transplanting 
organs between patients. Utilizing viable 
materials that are more readily available can help 
to overcome this major challenge in the field of 
regenerative medicine.  
Engineers have recently discovered that the 
complex structure of leaves can be broken down 
into various base, structural elements and 
systems comparable to those found in human 
cells and tissue layers. While animal and plant 
kingdoms differ in basic cellular properties and 
functions, the vascular networks found in the 
tissues of each are very similar. 
Figure 7 depicts the similarities in 
vasculature between animal and plant tissue 
layers [5]. Figure 7 shows the obvious 
macroscopic structural differences between a 
decellularized human organ and a decellularized 
leaf. However, the microscopic images depict the 
similarities between human and plant 
vasculature on the tissue level. This is due in part 
to the correlation between plant vasculature 
patterns and Murray’s Law, the accepted 
physiological rule describing the branching 
network structures found in the human 
cardiovascular system [48].  
 
 
Figure 7: The Similarities in Vasculature Between Animal 
and Plant Tissue Layers [48] 
Other similarities include varied mechanical 
properties common within the animal and plant 
kingdoms that allow for a variety of functions. For 
example, the polysaccharides such as cellulose 
that make up plant cell walls have high 
biocompatibility and strong wound healing 
capabilities [49]. Engineers believe that utilizing 
related vasculature and structures found in plant 
tissue can provide tissue engineers with viable 
living scaffolds that are available in much higher 
quantities and at much lower costs compared to 
transplanted human organ [5].  
The overall anatomy of a leaf is comparable 
to that of human tissue. Figure 8 depicts the 
cross-sectional anatomy of leaf tissue. Like 
human tissue, plant tissue is comprised of various 
functional layers. The upper epidermis provides 
protection, the mesophyll layers allow for 
transport within the tissue and house the leaf 
vasculature, and the lower epidermis provides a 
second layer of protection [50]. Found within the 
Figure 6: Schematic depicting the structure of cellulose [45]  
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epidermal layers of the leaf tissue are stomatal 
pores acting as openings into the mesophyll 
layers. These pores allow for oxygen diffusion 
through the inner vascular networks. Like 
capillary action found in human veins and 
arteries, the inner veins and vasculature in leaves 
allow for the movement of oxygen and other 
biomaterials throughout the entire tissue [48]. 
The vascular networks in plants provide the 
necessary movement of nutrients throughout 
each tissue layer, potentially providing a viable 
living structure for regenerative medicine 
applications to be used in human patients. 
 
 
 
III. PROJECT STRATEGY 
he following section outlines the overall 
approach for the project. This includes 
expectations for the project, objectives, and 
requirements. This provides a guideline to inform 
the final design and ensure that the design is best 
meeting the client’s needs and specifications. 
A. Client Statement 
Well characterized and reproducible macro- 
and microscale vasculature are needed for the 
development and assembly of engineered tissues. 
Macroscale vasculature must be perfusable and 
allow for manual and/or surgical anastomosis to 
non-biological hardware and native vasculature 
respectively. As a result, the anastomosis-capable 
end(s) of the macroscale vasculature should be no 
smaller than ~26G needle and be able to be 
sutured or otherwise attached to 
hardware/native vasculature. The scaffold or any 
other means of producing the microvasculature 
should be biocompatible and allow for both 
endothelial cell seeding and barrier formation 
within its lumen. Microscale vasculature can be 
entirely comprised of self-assembled, stabilized 
endothelial cell tubules. Microscale vasculature 
should be on the order of single digit to tens of 
microns in diameter. Microscale vasculature 
would ideally connect engineered or otherwise 
produced macroscale vasculature to make 
possible or at least enhance the transport of large 
molecules including from macroscale 
vasculatures spaced at least 200μm apart.  
Microscale vasculature can arise from 
vasculogenesis and/or angiogenesis. Size 
distribution, diffusive properties, and bio-
integration (cell seeding, barrier formation 
[macro-], and vessel density formation [micro-] 
should be known and controlled for. All materials 
must be biocompatible and cell viability of 
greater than or equal to 80% is acceptable. 
B. Design Requirements: Technical 
Presented next is an evaluation of critical 
design objectives and constraints. These have 
been grouped into three major design attributes 
for consideration: biological, mechanical, and 
industrial attributes. Objectives, presented in 
Table 4, are defined as statements of the client’s 
needs or wants.  
 
 
 
 
 
 
 
 
 
 
T 
Figure 8: Cross-Sectional Anatomy of Leaf Tissue [50] 
12 
 
Table 4: Objectives 
Biological Objectives 
● Successfully utilize the VEGF signaling pathway 
● Minimize time it takes for cellular movement from scaffold 
● Maximize the percentage of HUVECs that escape from scaffold 
● Provide a hydrogel matrix that maintains cell viability 
Mechanical Objectives 
● Allow for diffusion of oxygen and nutrients within the gel 
● Provide a scaffold with enough porosity to allow for cellular escape 
● Reduce internal pressure on cells and scaffold 
● Reduce shear stress/cell deformation within the gel 
● Provide a hydrogel matrix that allows for cellular movement 
Industrial Objectives 
● Allow for production of scaffold-gel construct in 4-6 weeks 
● Allow for large scale production of decellularized material 
● Allow for production of sterile gel in mass quantity 
● Translatable for large scale incubation for cell growth 
● Opportunity to automate cell loading process 
 
 
 
 
Next, the constraints for the project are 
presented. Constraints are defined as critical 
design components needed for design function; 
without these the design would fail. These 
attributes are highlighted in Table 5.
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Table 5: Constraints
 
Design functions are outlined Table 6. These 
functions are defined as important  
 
 
or relating to the operation of the design. 
 
 
 
Table 6: Functions 
 
 
 
 
 
 
 
 
Biological Constraints 
● Must allow for diffusion of oxygen and nutrients to the cells in the construct 
● Materials used must be proven biocompatible or similar to known biomaterials 
● Must allow for cellular adherence to scaffold 
Mechanical Constraints 
● Oxygen and nutrients must be able to diffuse within the gel 
Industrial Constraints 
● No one step in the process should take longer than 8 hours, not including incubation times 
● Must have consistent protocols, to ensure identical results 
Biological Functions 
● Allow for cellular movement within the gel, including endothelial cell escape 
● Cells must adhere to and escape from the scaffold 
Mechanical Functions 
● Gel must provide support and structure for the cells 
● Gel must allow for cellular movement 
● Stem must act as a scaffold for cell seeding 
Industrial Functions 
● Allow for a scalable and reproducible process 
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Finally, the specification for the design are 
presented. Specifications are defined as  
 
statements relating to operational limits, 
ranges, etc. These attributes are outlined in Table 
7. 
 
 
Table 7: Specifications 
Biological Specifications 
● Seed HUVECs and fibroblasts into stem scaffold at a ratio of 1:3 and a density of at least 100,000 [26]  
● 80% of cells must remain viable for 48 hours after seeding 
● Cells must escape the scaffold within 7 days [51]  
Mechanical Specifications 
● Vessel walls must maintain integrity under pressure of at least 150mmHg (calculated max pressure within 
a 10µm vessel using average blood pressure information provided by the American Heart Association) [52]  
● Cells must allow for 30-50% cellular escape from the scaffold 
Industrial Specifications 
● Production of structure must take between 4-6 weeks  
C. Design Requirements: Standards 
The following table outlines industry 
standards that would need to be adhered to and  
 
 
 
considered in the design of this project in 
accordance with ISO guidelines. 
 
  
Table 8: Key industry standards for the final design
D. Revised Client Statement 
Design a perfusable scaffold for endothelial 
growth and attachment to support cellular escape 
and migration from the original scaffold. The 
construct will incorporate a hydrogel matrix that  
 
 
 
 
allows for cell viability and proliferation after 
migration. The construct should allow the 
beginning stages of angiogenesis to occur and 
provide the foundation for further expansion of 
the matrix into a functioning vascular network. 
Important Industry Standards 
● Sterility (ISO 11737-2:2009, sterilization of medical devices) [53]  
● Endotoxin and pyrogens (ISO 10993-11: Systemic Effects) [54]  
● Blood transfusion (ISO/TC 76 - Transfusion, infusion and injection, and blood processing equipment for 
medical and pharmaceutical use) [55]  
● Biocompatibility (ISO 10993-1 Biological Evaluation and Biocompatibility Testing of Medical Devices) [56]  
● Human Cell Applications (ISO 13022:2012, Medical Products Containing Viable Human Cells - 
Applications of Risk Management and Requirements for Processing Practices) [57]  
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E. Project Approach 
To begin the project, the group first became 
familiar with the mechanisms and characteristics 
of angiogenesis and 3D printing. This allowed for 
the proper knowledge to adequately integrate the 
two. Research was conducted regarding previous 
studies involving angiogenic behavior of 
endothelial cells. Other experiments of interest 
included scaffold use for regenerative 
applications as well as different materials used 
for cell adhesion and migration. After initiating 
communication with the project sponsor, DEKA 
Research and Development Corporation, the 
team outlined expectations for the project, and 
specified short-term and long-term goals. The 
team determined that the overarching problem 
DEKA is facing with printing viable organs and 
tissues was the lack of established vasculature 
within the printing matrix. To overcome this, the 
team decided to focus the project on the initial 
steps of angiogenesis, mainly cellular adhesion to 
an existing vessel or structure, cellular escape 
from this vessel, and migration into the printing 
matrix. This would be accomplished by inducing 
cell movement from an existing scaffold through 
a gel. 
The group brainstormed different possible 
solutions for the problem, considering previous 
research in the designs. After narrowing down 
possible solutions, the group drafted preliminary 
designs for the project. These preliminary designs 
addressed certain criteria such as objectives, 
constraints, functions, and specifications. For 
testing purposes, the team chose to work with 
human mesenchymal stem cells (hMSCs) to 
model cellular adhesion based on their ability to 
be loaded with quantum dots. These quantum dot 
loaded cells would be useful in imaging the cells 
within the scaffold and verifying the design. 
Success with these cell types would verify the 
intended cellular behavior and lead to ultimately 
using human umbilical vein endothelial cells 
(HUVECs) in the final design because of their role 
in vessel formation within the body.  
Additionally, recent discoveries in utilizing 
decellularized plant material as scaffolds for cell 
seeding motivated the team to use such materials, 
specifically parsley stems and spinach leaves, as a 
main scaffold for the project. Different gels were 
also investigated, and the decision to use fibrin 
was based on its mechanical properties as well as 
its role in wound healing and high affinity for cell 
viability and movement [21] [26] [41] [51]. This 
would be used to create a scaffold-gel construct to 
allow for the escape and migration of HUVECs  
from the main plant stem. 
As mentioned, the scaffold-gel construct 
needed to exhibit certain characteristics to 
achieve the desired functions. These 
characteristics included: adequate cell adhesion, 
leaky vasculature allowing cellular escape, and 
cell viability and movement within the chosen gel. 
Cellular adhesion was monitored through 
fluorescent imaging of the quantum dot loaded 
cells seeded within the scaffold. Porosity was 
quantified by extruding microspheres 10µm in 
size, similar to the size of HUVECs, through the 
plant stems and counting the microspheres that 
escaped using a hemocytometer. Cell viability 
was tested by seeding fibrin gels with human 
fibroblasts and performing live/dead assays after 
48 hours to determine cell survival. The plant 
scaffold would be seeded with hMSCs and 
fluorescently imaged to ensure adequate 
adhesion of the human cells to the decellularized 
plant material. The seeded cells would then be 
monitored for migration into the gel from the 
plant scaffold, and fluorescent images would be 
taken of the gel to determine cellular escape from 
the original scaffold and migration through the 
gel. 
IV. DESIGN PROCESS 
he following section discusses the overall 
design process. This presents an in-depth 
analysis of the client’s needs as well as multiple 
conceptual and alternative designs that meet 
those needs. Additionally, preliminary studies 
and findings are presented, and the design 
selection is discussed. 
A. Needs Analysis 
To evaluate the importance of various design 
criteria, a pairwise analysis has been performed. 
This outlines major categories for the design. It 
has been discussed in detail with the client to 
determine which features are most important 
moving forward with a final design. From this 
analysis, it was determined that the most 
important criteria to be met were the diffusion of 
nutrients, induction of angiogenesis, and the 
induction of vasculogenesis/connectibility of 
T 
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vessels. The entire copy of the pairwise analysis 
can be viewed in Appendix A.  
B. Conceptual Designs, Modeling, Feasibility  
Based on the design criteria, different designs 
were developed and explored through prototypes 
and feasibility studies. The design was narrowed 
down to one optimal design for the project based 
on the results of these prototypes and studies. 
1. Concept Map 
The concept map in Figure 9 depicts the 
initial thought process and demonstrates how 
each component fits together to ultimately result 
in vasculogenesis. 
 
Figure 9: Concept map for vasculogenesis 
2. Conceptual Designs 
Here, the main concept of the vascular 
network is presented in Figure 10. In this design, 
two decellularized spinach leaves are placed 
within a gel matrix and the stems of both leaves 
are perfused with human endothelial cells 
(HUVECs). This would be completed using a 
bioreactor to allow constant perfusion. Ideally, 
the endothelial cells would then escape into the 
gel through the natural vascular scaffold provided 
by the veins in the leaf. The endothelial cells 
would then begin to exhibit angiogenic markers 
and there would be visible sprouting and cellular 
movement through the gel. The movement of the 
cells through the gel matrix would eventually 
result in the growth of new blood vessels and the 
formation of a full vascular network (labeled as 
the vascular network in Figure 10). 
 
 
 
Figure 11 depicts a second conceptual design 
through which two decellularized parsley stems 
would be laid side by side within a gel matrix. The 
inside of two decellularized parsley stems will be 
seeded with HUVECs after being treated with 
fibronectin, a cellular adhesive protein that would 
help to increase the likelihood of the cells sticking 
to the plant stem wall. The outside of each parsley 
stem will be coated in growth factors that would 
act to promote cellular escape of the HUVECs 
through the parsley stem wall and into the gel 
matrix. Once the cells would escape through the 
parsley stem walls, they would migrate through 
the gel matrix and begin forming new blood 
vessels; this would eventually lead to the 
formation of a full vascular network within the 
gel.  
 
 
 
 
The next conceptual design, depicted in 
Figure 12, includes again the use of growth factors 
to stimulate angiogenesis. Similarly, this design 
consists of two decellularized parsley stems 
positioned side by side within a gel matrix. In this 
design, the growth factors would be extruded in 
Figure 10: Conceptual Design 1, Vascular Network 
Figure 11: Conceptual Design 2, Coated Growth Factors 
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the gel between the two stems. Again, the inside 
of both stems would be seeded with HUVECs. The 
extrusion of growth factors within the gel matrix 
would in theory encourage endothelial escape 
from the plant stem, followed by the sprouting of 
new blood vessels within the gel matrix in the 
direction of the growth factors. This would 
ultimately lead to the continued growth of these 
blood vessels and the creation of a vascular 
network (not depicted in Figure 12) between the 
stems. 
 
 
 
The final conceptual design depicts two 
decellularized parsley stems placed within a gel 
matrix. Each will be seeded internally with 
HUVECs and externally with human fibroblasts. 
Figure 13 shows how the fibroblasts on the 
outside of the stems will act as natural 
chemoattractants via their natural secretion of 
growth factors. This would promote cellular 
escape of the HUVECs through the parsley stem 
wall and induce sprouting of vessel walls from the 
parsley stem into the gel. This would ideally lead 
to the continued growth of new blood vessels that 
would develop into a full vascular network within 
the gel matrix.  
 
 
3. Feasibility Studies 
The following studies aim to determine the 
feasibility of different experimental designs. This 
section summarizes some of the initial tests 
conducted to ensure the success of the project. 
The tests looked at key features such as 
biocompatibility, decellularization, cellular 
adhesion, porosity treatments, and gel 
characterization. 
 
i. Biocompatibility 
Throughout the duration of this project, there 
was a concurrent study conducted to analyze the 
biocompatibility of decellularized plant scaffolds. 
This study implanted a decellularized spinach 
leaf subcutaneously in rat stomachs and kept the 
implant within the rat for up to 4 weeks. The 
sections of the rat were dissected and processed 
using histology techniques. The final images, 
included in the preliminary data, model the 
immune response within the rats. 
 
ii. Decellularization of Parsley Stems 
  Since this project analyzed the potential for 
utilizing parsley stems as a scaffold, the ability to 
decellularize parsley was analyzed. The parsley 
was submerged in 1% SDS and left on the rotator 
for 48 hours. Then, the stems were transferred to 
a 0.1% Triton-X-100 in a 10% sodium chlorite 
bleach for another 48 hours. Finally, the stems 
were then rinsed in deionized water (diH20). The 
decellularization of these stems was assessed by 
appearance compared to the spinach leaves 
 
iii. Cell Adhesion 
To ensure the cells would adhere to the 
decellularized parsley, a feasibility study was 
conducted, mimicking the methods used in the 
paper Gershlak, et al.  
A dried, decellularized parsley stem was 
rehydrated in sterile PBS, then left under UV light 
for 20-30 minutes. A 10μg/mL solution of 
fibronectin was created in sterile PBS. A syringe 
was used to draw up air, 100μL of the 10% 
solution, and then air. The first bubble of air was 
pushed through the stem to rid the stem of excess 
PBS. The solution was pushed through until just 
visible as a bubble formed on the opposite end. 
The stem was then placed in a new petri dish and 
incubated in 37oC and 5% CO2 for 30-45 minutes. 
One end of the stem was then tightly sutured, and 
500,000 fibroblasts, suspended in 100μL of 
media, were inserted into the stem with the 
syringe. The open end of the stem was then tightly 
sutured and placed in a petri dish. The stem was 
left to sit for 1-2 hours. Then, 15mL of media was 
added to the petri dish. The dish was left inside 
an incubator at 37oC and 5% CO2 for 76 hours. 
After 76 hours the stem containing cells was fixed 
in 4% paraformaldehyde. 
Figure 12: Conceptual Design 3, Extruded Growth Factors 
  Figure 13: Conceptual Design 4, Fibroblast Coating 
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iv. Porosity Treatments 
Different treatments were explored to 
improve the porosity of the parsley stems and 
allow for improved diffusion out of the scaffold. 
Three different base treatments (NaOH, KOH, 
and Na2CO3) were explored. Observations about 
the stem integrity and availability to diffuse were 
made. Additionally, treatments of 2.5% cellulase 
were tested. The cellulase was allowed to digest 
for 20 minutes and 40 minutes to observe the 
effect upon the stems and diffusion of the cells. 
 
 
5. Gel Characterization 
Finally, different gels were explored for 
support in cell migration. After conducting 
research about existing gels, the design was 
narrowed down to two main options: fibrin or 
gelatin. Both gels were made, allowed to gelate, 
and were sterilized. The study assessed ease of 
gelation and filtering, time to gelate, temperature 
for gelation, and overall characteristics of the 
gels.  
 
6. Histology 
Sections of the stem coated with HUVECs 
were taken along the axial and transverse faces. 
Sections were taken at 10μm and stained with an 
H&E stain to look for the presence of cell nuclei 
and cytoplasm within the decellularized parsley 
stem. 
4. Preliminary Data 
i. Biocompatibility 
The biocompatibility of the scaffolds was 
tested by implanting the decellularized leaves 
subcutaneously on the stomach of rats. The 
results of the 4-week test are presented in Figure 
14. 
 
Figure 14: Results from biocompatibility testing on 
decellularized spinach leaves 
Figures 14-D, 14-E, and 14-F serve as a 
magnified image of the box indicated in Figures 
14-A, 14-B, and 14-C. At one week, the scaffold is 
visible within the rat. By 2 weeks the body has 
encapsulated and begun to wall off the material, 
indicating an immune response; however, by 
week 4, the scaffold has started to become 
integrated into the subcutaneous layer. This 
suggests that the material is in fact biocompatible 
and would serve as a viable scaffold for cellular 
adhesion and eventual implantation into the 
body. 
 
ii. Decellularization of Parsley 
From the preliminary testing, we have 
obtained data relating to the decellularization of 
parsley stems. Figure 15 is a 2in parsley stem after 
being treated with SDS and 0.1% Triton X-100 in 
a 10% sodium chlorite bleach. This protocol was 
obtained from Gershlak et al. and yielded a 
decellularized parsley stem containing no traces 
of pigment nor plant cells after being treated with 
the preceding chemicals, as seen in the Figure 15. 
This served as a positive indicator that parsley 
could be decellularized as in the study done by 
Gershlak et al [5]. 
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Figure 15: Decellularized parsley stem, approximately 2in 
in length 
iii. Cell Adhesion 
Cellular adherence was tested in two different 
plant models: spinach and parsley. The Gershlak, 
et al. paper demonstrated the ability to seed 
human umbilical endothelial cells (HUVECs) into 
the main stem of the decellularized spinach leaf. 
Based on that research, the following experiment 
aimed to test cellular adhesion to the 
decellularized parsley stem and compare the 
results to the established cellular adhesion of 
decellularized spinach leaves. The following tests 
seeded fibroblasts into a parsley stem to confirm 
the viability of the scaffold for cellular adhesion. 
The stem was hydrated in sterile PBS and 
sterilized using UV sterilization, and pre-coated 
with fibronectin to increase cellular adhesion to 
the plant material. The parsley stem was seeded 
with 500,000 fibroblasts and left to incubate for 
three days. Figure 16 presents the histology 
samples, stained with an H&E stain. 
 
 
 
 
 
 
Figure 16 demonstrates the cellular adhesion 
for the potential parsley scaffold. As seen through 
the histology sample, the parsley stem appeared 
to have little to no seeding after three days and 
remained consistent with past seeding attempts. 
The lack of cells lining the inside of the parsley 
stem indicates that this scaffold would allow for 
inadequate cellular adhesion. 
 
iv. Porosity Treatments 
Porosity of the plant stems was analyzed to 
ensure diffusion from the scaffold was possible. 
This was modeled with parsley stems and the 
stems were treated with a 2.5% cellulase solution 
over different time points. The major initial 
conclusions are outlined in Table 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Fibroblasts seeded into a 2in, decellularized 
parsley stem (800,000 cells) for 48 hours 
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Table 9: Observations from different treatment 
considerations
 
From these conclusions, cellulase treatments 
under an hour were interpreted to be the most 
promising solution to increasing porosity and 
diffusion. This data would be useful for future 
experiments in establishing the appropriate 
porosity for cellular escape through the chosen 
plant scaffold. 
Additionally, the stems with the most 
promising initial structure post treatment 
(cellulase treatments under an hour) were 
perfused with 200,000 microspheres, 10μm in 
size. These microspheres were collected and 
counted using a hemocytometer and the 
percentage of microspheres escaped was 
calculated. These results are also presented in 
Table 10. 
 
 
 
 
 
 
 
Table 10: Percentages of 10µm escaped with different 
treatment times of 2.5% cellulase 
Treatment n = Average * 
No Treatment 3 28.0 ± 7.07 
20 Minutes 
Cellulase 
1 27.8 ± 0** 
40 Minutes 
Cellulase 
2 35.7 ± 16.3 
*Outliers were defined as stems that burst, or took greater than 24 hours to rehydrate leading to 
unreadable, or unrepresentative data 
**Two of the three samples were considered outliers, standard deviation of zero is not 
representative of the true deviation 
 
Examining the average percentage of 
microspheres escaped, it appears that the stems 
not receiving any treatment had the highest 
percentage of microspheres escaped with the 
lowest standard deviation. From these averages, 
it appears that the 40-minute cellulase treatment 
has the highest percentage of escaped 
microspheres; however, these stems also had the 
highest standard deviation. The 20-minute 
cellulase treatment did have the lowest standard 
deviation when the outliers would have been 
excluded, but that was due to a sample size of one, 
resulting from burst stems during the procedure. 
v. Gel Characterization 
2% Gelatin was created by heating the 
solution to 50oC until it became a viscous liquid, 
at which point it was filtered in the biosafety 
cabinet using a 0.8µm filter. It was allowed to 
gelate in the fridge overnight. Finally, a solution 
of equal volumes of fibrinogen and thrombin 
were incubated, to form a fibrin gel. Each of the 
components were filtered individually before 
mixing to make fibrin. Once the solution was 
removed from the incubator 30 minutes later, a 
gel was formed. An initial comparison of the two 
gels is presented in Table 11. 
 
 
 
 
 
Treatment Observations 
NaOH Stem appears stiffer and 
thinner 
KOH Stem appears more 
degraded 
NaCO2 Stem appears very 
degraded and much 
softer 
Cellulase 20 minutes Stem appears intact 
Cellulase 40 minutes Stem appears intact 
Cellulase 12 hours Stem is majorly 
degraded 
Cellulase 18 hours Stem is nearly entirely 
degraded and cannot 
hold original shape 
Cellulase 24 hours  Stem is entirely 
degraded and unusable 
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Table 11: Comparison of fibrin and gelatin for use in the 
final design 
Fibrin Gelatin 
Gelation at 37oC Gelation at -4-10oC 
Known player in wound 
healing 
Needs crosslinking to 
remain a gel in 
incubator 
Biocompatible Biocompatible 
 
Based on the observations presented in Table 
11, fibrin appears to be the more feasible gel with 
better potential for success. Fibrin is a known 
agent involved in wound healing and other 
cellular processes within the body and would thus 
be useful in working with our chosen cells to 
promote the growth of new blood vessels. 
C. Alternative Designs 
Prior to finalizing a concept and final design, 
we drafted several alternative designs. Figure 17 
depicts a single spinach leaf suspended in a gel or 
liquid-like solid media. The endothelial cells are 
then perfused through a bioreactor. The intent of 
this design was to prompt vessel growth across 
the leaf and into the gel. 
 
 
Figure 17: Alternate Design 1, Spinach Leaf Suspended in 
Gel 
 
Figure 18 shows a side view of another 
alternative design. It shows two leaves 
sandwiching an area of gel between them. The 
premise of this concept was to print either 
columns (1) or fibers (2) of cell adhesive material 
from the surface of one leaf, through the gel, to 
the surface of the second leaf. This cell adhesive 
material would guide the endothelial cells 
through the gel and ultimately sprout vessels. 
 
 
 
Figure 18: Alternative Design 2, Columns of Cell Adhesive 
Material 
 
Figure 19 shows two spinach leaves 
positioned side by side submerged in a gel rather 
than stacked into a sandwich. To ease the stress 
of creating branched vessels in the Z direction, 
this design would allow for vessel sprouting in the 
same plane as the existing leaf vasculature.  
 
 
Figure 19: Alternative Design 3, Leaves Side by Side 
 
This design, depicted in Figure 20 shows a 
single spinach leaf within a gel. As endothelial 
cells are perfused through the leaf stem, 
chemoattractants and/or growth factors would be 
printed in the Z direction within the gel. The 
endothelial cells would ideally “climb” the 
chemoattractants and sprout vessels in the Z 
direction within the gel. 
 
 
Figure 20: Alternative Design 4, Growth Factors in Gel to 
Guide Growth 
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A final alternative design, depicted in Figure 
21, would be printing microfluidic channels as 
guides for endothelial cell migration within a gel. 
These channels would be constructed of a cell 
adhesive material (such as fibrin or collagen) to 
promote cell adhesion.  
 
 
Figure 21: Alternative Design 5, Microfluidic Channels 
D. Final Design Selection 
Following these preliminary studies, the 
team came up with a final design, pictured in 
Figure 22. Decellularized spinach leaves, pictured 
in Figure 22-A, were chosen as the scaffold for 
this design based on the proven positive cellular 
adhesion to the spinach leaf stems. Figure 22-B 
shows the potential for modular designs using the 
decellularized spinach leaves for the final design. 
In a similar manner, the HUVECs would be 
seeded along the inside of the spinach leaf stems, 
and the cells would theoretically escape through 
the natural vascular of the spinach leaf veins. As 
pictured in Figure 22-C, this design would then 
be placed within a gel matrix. The HUVECs would 
escape into the gel matrix. If necessary, growth 
factors may be added to the gel matrix to 
encourage the growth of new blood vessels in 
specified directions. This would ultimately lead to 
the development of a full vascular network within 
the gel matrix. In terms of 3D bioprinting, this 
structure and vascular network would be within 
the gel matrix that the designated cell type is 
printed into. This would allow for the proper 
nutrient diffusion to the printed cells within the 
matrix. This process is depicted in Figure 22-C. 
 
Figure 22: Schematic of final design construct 
 
V. FINAL DESIGN 
VERIFICATION 
he following section presents the raw data 
from tests for each individual component of 
the project design. The experiments aimed to 
ensure the functionality of the construct as a 
whole by evaluating cellular adhesion of the cells 
within the scaffold, escape from the scaffold, and 
migration through the gel. The compilation of 
these components demonstrates the proof of 
concept needed for the success of the final design. 
T 
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As previously discussed in section IV, Design 
Process, a concurrent study confirmed the 
biocompatibility of the scaffold, so it was not 
explicitly examined in our results. 
A. Cell Adherence 
 
Cellular adherence of human cells to 
decellularized spinach leaves was tested with 
quantum-dot (Q-dot) loaded human 
mesenchymal stem cells (hMSCs). Cells were 
loaded with Q-dots 24 hours prior to seeding 
within decellularized leaves. 500,000 cells were 
seeded into a decellularized spinach leaf and 
cultured over 36 hours. These cells were then 
imaged on an inverted scope with fluorescents. 
Figure 23 presents cell seeding within the spinach 
leaf. The red fluorescents represent Q-dot loaded 
cells. 
 
 
Figure 23: Q-dot loaded cells seeded within a decellularized 
leaf for 36 hours 
The red fluorescents are dispersed 
throughout the inside of the leaf, indicating 
cellular adhesion to the leaf. The cells highlighted 
in the image display the distinct shape of Q-dot 
loaded hMSCs, being expressed only in the 
cytoplasm and not the nucleus. Thus, this 
indicates that the fluorescent signal is due to the 
cells rather than autofluorescence from the leaf. 
B. Cellular Escape  
To model the diffusion of cells from the 
scaffold, microspheres, 10μm in size, were loaded 
into a 5mL syringe. The microspheres were 
perfused through the stem using an electronic 
syringe extruder. 200,000 microspheres were 
resuspended in 5mL of diH20 and extruded 
through the stem at a rate of 200μL/min. The 
average percentage of microspheres escaped 
from decellularized spinach leaves, n of 3, are 
outlined in Table 12. 
 
Table 12: Percentages of microspheres escaped, 10µm in 
size, from the original vessel, n = 3 
Average Percent 
Escaped 
Standard Deviation 
37.5 3.31 
 
The average amount of microspheres escaped 
from a decellularized spinach leaf was 37.5% ± 
3.31. This falls within the specification for 30-
50% escape from the scaffold to allow for cellular 
escape and migration. This would indicate a 
vascular scaffold leaky enough to promote 
cellular escape, however not so leaky that all the 
cells seeded within the leaf would escape 
uncontrollably. 
C. Cellular Migration 
 
Cellular viability and migration throughout a 
fibrin gel is well understood and studied, as 
discussed previously [21] [26] [41] [51]. Due to 
time and resources, migration could not be 
studied in the following tests, however, the 
results in literature provide results to allow for a 
confident selection of a supportive gel matrix. 
Based on this knowledge, fibrin gel was selected 
as the ideal gel for the final construct. Despite 
this, the viability of the gel was confirmed with 
the specified fibrin concentration to ensure 
repeatability of the researched procedures. 
Fibroblasts were suspended in a 2.5mg/ml fibrin 
gel, allowed to solidify for 8hrs and cultured for 
72hrs. Then a live dead assay was performed on 
the gels and analyzed under a fluorescent scope. 
In the following images, red represent dead cells 
while green represents live cells. The blue 
represents the nuclei of the cells. The results from 
these tests are presented in Figure 24. 
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Figure 24: Live/dead assay of fibroblasts after 72 hours in 
fibrin gel. Approximately 500,000 cells seeded 
Figure 24-A is an image of the live stain and 
Figure 24-B is an image of the nuclei stain. It is 
evident that many of the nuclei align with the live 
cells, indicating a plethora of live cells within the 
fibrin gel. Figure 24-C is an image of the dead 
stain. There are little cells that are present in the 
stain, confirming again that most of the cells, if 
not all of the cells, are viable after 72 hours within 
the fibrin gel. 
VI. FINAL DESIGN AND 
VALIDATION 
he following section discusses the overall 
procedures for ensuring the final design 
meets the listed specifications and standards. It 
also discusses the project’s overall impact on 
society. The methodology breaks down the exact 
experimental means used to confirm the success 
of the project. The design was evaluated first by 
ensuring cellular adhesion was possible in the 
decellularized scaffolds. Then once adequate 
adhesion was confirmed, the ability for the 
scaffolds to allow for cellular escape was tested. 
Finally, the cell matrix was chosen based on 
literature about cell viability and migration 
within a fibrin gel. The compilation of these steps 
confirms the first steps of angiogenesis, cellular 
escape and migration, to eventually allow for the 
formation of blood vessels. 
A. Methodology 
The results of this project revealed adequate 
cell adhesion in spinach leaf scaffolds and 
sufficient cellular escape from the main veins. 
These components suggest that the initial stages 
of angiogenesis, cellular escape and migration, 
are feasible using decellularized spinach leaves as 
a cellular scaffold. 
1. Decellularization of Parsley Stems 
Spinach leaves were treated with 10% sodium 
dodecyl sulfate (SDS) for 24 hours, and then 
treated with 0.1% Triton-X-100 in a 10% sodium 
chlorite bleach in deionized water solution for 72 
hours. After, they were rinsed with deionized 
water to remove the bleach. 
2. Mammalian Cell Culture 
Human mesenchymal stem cells (hMSCs) 
were cultured using a media containing IMDM, 
2% Glutamax, 1% Penicillin Streptomycin, and 
10% Fetal Bovine Serum. 
3. Quantum Dot Loading 
12.5μL of quantum dots were added to 10 mL 
of human mesenchymal stem cell media. Human 
mesenchymal stem cells were then exposed to 
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this media and allowed to incubate for 24 hours. 
Quantum dot loaded cells emit a specific 
fluorescent profile underneath the microscope, 
which can be described as a red fluorescent ring 
surrounding the nucleus of the cell. 
4. Cell adherence to decellularized scaffolds 
A lyophilized, decellularized spinach leaf was 
cut around the main vein to expose the vessels 
and reduce the overall surface area. Figure 25 
demonstrates the cut for one spinach leaf. The 
leaf was then rehydrated with sterile PBS. The 
leaf was then left under UV light for 20-30 
minutes. A 10μg/mL solution of fibronectin was 
created in sterile PBS. A syringe was used to draw 
up air, 100μL of the 10% solution, and then air. 
The first bubble of air was pushed through the 
main vein to rid the leaf of excess PBS. The 
solution was pushed through until the media was 
visible in the vein and the air was mostly removed 
from the syringe. The leaf was then placed in a 
new petri dish and left to dry at room 
temperature for 60 minutes. Then, 500,000 
quantum dot loaded human mesenchymal stem 
cells, suspended in 200μL of media, were 
inserted into the leaf with the syringe. The leaf 
was then placed into a petri dish. The leaf was left 
to sit for 8 hours in a humid environment, then 
15mL of media was added to the petri dish. The 
dish was left inside an incubator at 37oC and 5% 
CO2 for 36 hours. After 36 hours the leaf 
containing cells was imaged with an inverted 
fluorescent scope.  
 
 
 
5. Testing Cellular Escape with Microspheres 
The syringe pump extruder was utilized to 
ensure a steady flow rate of microspheres into a 
rehydrated spinach leaf. The system was set up as 
presented in Figure 26. The leaf was rehydrated 
in PBS and 200,000 blue, dyed, microspheres, 
10µm in size, were perfused through the leaf at a 
rate of 200μL/min and the escaped microspheres 
were collected in a petri dish. The microspheres 
were centrifuged for 5 minutes at 0.2rcf and then 
were counted using a hemocytometer to 
determine the percent escaped. Any 
microspheres not perfused through the leaf were 
counted separately and excluded from the 
original number of microspheres perfused.  
 
 
6. Production of Fibrin 
A 5mg/mL concentration of fibrinogen was 
prepared in a 20mM HEPES solution containing 
0.9% NaCl. 0.5U/mL solution of thrombin was 
prepared in a 40mM solution of CaCl2. The 
solutions were then filtered separately in a 
0.22µm filter and combined at 1:1 ratio. The gel 
was incubated at 37oC and 5% CO2 for 30-60 
minutes.  
 
7. Cell Viability within Gels 
Fibrin was made as described in the section 
titled “Production of Fibrin”; however, the total 
volume when calculating concentration included 
the addition of 50µL of media for seeding the 
cells. A 1000µL gel was produced. The cells were 
mixed first with the fibrinogen, then the 
fibrinogen and thrombin were allowed to gel at 
37oC for 30-60 minutes in a 24-well plate. 
Figure 25: Decellularized spinach leaf, 
preparation set up for cell seeding 
Figure 26: Experimental set up for microsphere extrusion 
experiments 
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Afterwards, 1mL of media was added to the well. 
After 48 hours, a live/dead assay was performed 
on the gel to determine cell viability. Two 
solutions were made: solution 1 contained 1.0mL 
of Serum Free DMEM, 2.0µL of Ethidium 
Homodimer-1, and 0.5µL of Calcein AM, solution 
2 contained the same concentrations with the 
addition of 0.5µL Hoescst Dye. Each solution was 
mixed within 1 hour of use. The media in each 
well was aspirated. Approximately 80µL of 
solution 1 was added to each well and left to 
incubate at 37oC for 15 minutes. Then 
approximately 80µL of solution 2 was added to 
each well and left to incubate at 37oC for 15 
minutes. The dyes were then aspirated from the 
plate and the cells were washed with 1x PBS three 
times. The cells were then fixed in 4% 
paraformaldehyde for 10 minutes at room 
temperature and imaged under an inverted 
fluorescent microscope.  
8. Microscopy 
 All cellular images were taken using 
fluorescent microscopy on an inverted 
microscope and all other images were taken on an 
upright scope without the use of the 
corresponding fluorescent wavelength. 
B. Verification of Standards 
The following is a list of the standards 
intended for this project to comply with and a 
brief description of how this project has met each 
standard.  
1. Sterility (ISO 11737-2:2009, sterilization of 
medical devices) 
In compliance with ISO 11737-2:2009, the 
International Standard on Sterility of Medical 
Devices, all cell culture practices, gel formation, 
scaffold seeding, and material handling was done 
in a sterile biosafety cabinet and/or sterile 
incubator. All tools used for these practices were 
autoclaved prior to use, and all materials coming 
into contact with cells were sterilized with rinses 
of ethanol and PBS [53].  
2. Endotoxin and pyrogens (ISO 10993-11: 
Systemic Effects) 
In compliance with ISO 10993-11, the 
International Standard on the Evaluation of 
Systemic Sterility, all components of the final 
construct have been evaluated for use within the 
body. The cells being used, human mesenchymal 
stem cells (hMSCs) and lymphoma fibroblasts, 
the gel being used, fibrin, and chemoattractants 
being used, VEGF/fibroblasts, are all sourced 
from and/or secreted naturally by the human 
body. Thus, utilizing these natural materials 
should avoid any systemic toxicity. The 
decellularized plant scaffolds being used for this 
project have undergone in vivo biocompatibility 
testing and have shown minimal inflammatory or 
toxicity response within the body [54]. 
3. Blood transfusion (ISO/TC 76 - 
Transfusion, infusion and injection, and blood 
processing equipment for medical and 
pharmaceutical use)  
In compliance with ISO/TC 76, the 
International Standard for Blood Transfusion 
and Processing for medical or pharmaceutical 
use, all handling and testing of biological 
materials and materials intended for contact with 
human blood have been standardized, and 
quality testing for the industrial setting has been 
considered [55].  
4. Biocompatibility (ISO 10993-1 Biological 
Evaluation and Biocompatibility Testing of 
Medical Devices)  
In compliance with ISO 10993-1, the 
International Standard for Biological Evaluation 
and Biocompatibility Testing of Medical Devices, 
all components of the final construct have 
undergone biocompatibility testing or have been 
previously deemed biologically safe for use within 
the body. In vivo testing of the decellularized 
plant constructs being used have shown minimal 
signs of an inflammatory response in the 
surrounding cells and tissue layers. All other 
components are sourced from within the body 
and have been deemed biologically safe [56]. 
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5. Human Cell Applications (ISO 
13022:2012, Medical Products Containing 
Viable Human Cells - Applications of Risk 
Management and Requirements for Processing 
Practices)  
In compliance with ISO 13022, the 
International Standard on Human Cell 
Applications and Risk Management, all cells 
being used in the final construct of this design 
have been handled sterilely - handled within a 
biosafety cabinet, cultured in a sterile incubator, 
frozen (if necessary) in sterile vials, loaded into 
scaffolds within a biosafety cabinet. The risks and 
benefits of using such materials have been 
evaluated, and the manufacturability of this 
construct utilizing human cells has been 
addressed throughout the project [57]. 
C. Economics 
 
The final design construct for this project will 
significantly reduce the cost of organ/tissue 
replacement. Utilizing this construct would 
eliminate the need to use donor organs and 
undergo expensive surgical procedures, thus 
saving patients and insurance agencies money. 
The use of decellularized plant materials as 
scaffolds within this construct positively 
contributes to the agricultural industry and helps 
to maintain jobs for farmers. With these positive 
economic impacts, the overall revenue for the 
healthcare field, especially surgeons and 
transplant specialists, would decrease, and 
insurance coverage for this type of procedure 
must be evaluated. 
D. Environmental Impact 
While utilizing plants such as spinach and 
parsley would reduce the amount of fabricated 
materials used in tissue engineering, the increase 
in plant usage would negatively impact the 
environmental availability of these products. 
If/when this construct undergoes production 
within an industrial setting, the rate at which 
these plant materials will be used will drastically 
increase due to manufacturability needs 
production. While the availability of these 
materials for human consumption might 
decrease, the shift would be for use within the 
healthcare field, ultimately helping to save the 
lives of patients. 
E. Society Influences 
The main societal influence of this project is 
the use of spinach leaves as a medical application. 
The idea of such an application is highly shocking 
to most individuals and may not be well received 
for those in need of the technology. Currently, the 
use of spinach leaves for medical research has 
resulted in a lot of societal attention, with some 
speculation coming from people who may not 
understand the intended application or potential 
of this material. This construct would have a large 
positive societal influence as well. Individuals 
able to receive implants as a result of this 
technology would be able to regain normal lives, 
with less hospital stays. 
F. Political Ramifications 
Utilizing plants as tissue engineering 
scaffolds would allow for easier organ transplants 
in areas of the world where human donor organs 
are not always readily available. However, 
dependent upon the agriculture of the country, 
these types of produce might not be available in 
excess, or at all, to use for tissue engineering. This 
has the potential to result in biased applications 
of this construct to within areas with abundant 
economic and agricultural resources. As a result, 
this can be seen as a medical advancement 
intended for first-world nations. 
 
G. Ethical Concerns 
This product would increase the quality of life 
for those receiving this procedure by allowing 
them to live away from the hospital. Patient well-
being would no longer be an inhibitory factor. 
Additionally, this alleviates ethical concerns for 
the use of animal products in certain transplants. 
The design of this product would be animal 
product free, providing an ideal solution for all 
lifestyles. Matching donor organs to patients 
would no longer pose as a problem for transplant 
patients, significantly reducing the amount of 
time the patient would need to live unhealthily 
prior to organ replacement. 
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H. Health and Safety Issues 
This construct would allow for higher patient 
survival rates by reducing the wait time for donor 
organs. Reducing the amount of time patients are 
waiting for replacement organs likely would have 
a positive correlation to the average lifespan of 
patients needing organ transplants. With any 
implant, there is a risk of malfunction or 
infection, which could cause negative health 
effects for the patient. However, with current 
studies analyzing biocompatibility and 
inflammatory response in these tissues, the 
decellularized plant materials do not appear to 
have any negative response. This final construct 
has complied with relevant international 
standards pertaining to various elements 
including sterility, biocompatibility, and product 
manufacturing. 
I. Manufacturability 
The project is fairly reproducible and could 
be scaled up to a larger scale process. Many of the 
steps required (i.e. decellularization, incubation, 
seeding cells) can be easily scaled up. The only 
step to date that would cause potential issues in 
the process is the cannulation of the stems. This 
step has to be done by hand due to the delicate 
nature of the decellularized material. However, if 
an assembly line is established, this process can 
be easily optimized. Other important 
considerations for manufacturing this construct 
would be standardizing the necessary protocols, 
the time needed to create this construct, and the 
efforts needed to produce this construct on a 
large scale. 
 
Table 13: Estimated cost of manufacturing 
Item Cost 
Decellularization $20.00 
Construct Assembly $2,400.00 
Equipment $580.00 
Total Cost per 
Construct 
$3,000.00 
 
In regard to the pricing of the construct, the 
Table 13 is a breakdown of the cost to engineer 
one of these leaf constructs. Decellularization 
steps include purchasing spinach leaves, 
detergents and bleaches. The Construct Assembly 
price includes proteins, cells, and cell media. 
Equipment is representative of general 
laboratory equipment such as incubators, 
pipettes, pipette tips and cell culture dishes. The 
estimated total cost of this construct is $3,000. 
This estimate does not include the cost of 3D 
bioprinting into the construct, nor does it include 
other factors like the actual surgery once the 
organ is produced, quality control, or other 
additional upscale processes. 
J. Sustainability 
Production of our construct would reduce the 
negative industrial effects on the environment by 
eliminating the role of synthetic materials in 
tissue engineering. Utilizing plant structures and 
human cells/proteins would eliminate the need to 
manufacture materials in an industrial setting. 
While this process would emit less industrial 
fumes during production, automation of 
production would cause an increase in electricity 
usage due to incubation, automation of cell 
seeding processes, etc. 
VII. DISCUSSION 
ecellularized plant scaffolds were proven to 
be a viable option for seeding cells and the 
biocompatibility of the materials have been 
confirmed [5]. Since the scaffolds can be seeded 
and induce very little immune response, the 
option of using decellularized plants as scaffolds 
for promoting angiogenesis was explored. In the 
experiment conducted, cellular adhesion was 
tested in two different plant models (spinach and 
parsley). The two were compared and spinach 
was chosen as the superior scaffold. After 
adequate adhesion was obtained, cellular escape 
was modeled from the scaffold utilizing 
microspheres 10μm in size to model endothelial 
cells. These tests were performed on scaffolds and 
the microspheres were collected to measure the 
percent escape. Regarding cell movement within 
a gel, previous research has shown the ability of 
endothelial cells to move within fibrin gel 
matrices and supported the decision for the gel 
matrix. The compiled success of each of these 
components would allow for the initial stages of 
angiogenesis to occur. Angiogenesis begins with 
endothelial cell escape and migration to allow the 
new blood vessels to form. Therefore, ensuring 
adequate adhesion, escape, and migration would 
allow new vessels to form [6]. Once these new 
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vessels have formed, cells can be printed onto the 
construct to form tissues, and eventually 
functioning organs. 
In comparing the two different plant 
materials, it is evident that there was greater 
adhesion in the spinach leaf. Despite previous 
successes in the cell seeding of parsley stems, our 
team was unable to achieve adequate cell 
adhesion. Histological samples of a parsley stem 
seeded with fibroblasts can be seen in Figure 16. 
This was due to the large surface to volume ratio 
of the stem, as well as the time constraint the 
team had to follow. To model cellular adhesion in 
spinach leaves, quantum dot loaded human 
mesenchymal stem cells were seeded and allowed 
to incubate for 36 hours. The results from this 
experiment can be seen in Figure 23. Cellular 
adhesion is evident considering quantum dot 
loaded human mesenchymal stem cells have a 
specific fluorescent profile characterized by a red 
color outlining the nucleus. Considering the 
cellular adhesion that was obtained when using 
decellularized spinach leaves as a scaffold, the 
team decided to continue with this plant material 
as a scaffold.  
In the studies modeling cellular escape, the 
results in Table 12 show that 10 um microspheres 
had an average of 37.5% escape from the spinach 
leaf scaffold when perfused through. Although 
there is no published literature about the 
necessary percentage of cellular escape for 
angiogenesis, we believe 30-50% to be an 
appropriate amount, as it would allow for some 
escape and the formation of new vessels without 
a total loss of cells. The percent escape calculated 
from the leaf shows that the scaffold is porous 
enough to allow for cellular escape, but not so 
porous that seeded cells will not be able to adhere 
to the scaffold once perfused. 
 Experiments were then conducted to ensure 
that cells would be able to survive in a fibrin gel 
matrix. 1000μm fibrin gels were composed of 
5mg/ml of fibrinogen and 0.5U/ml. They were 
then seeded with fibroblast cells. Using a 
live/dead assay, cell survival was evident after 48 
hours within the gel. Due to time constraints and 
several other factors, cellular migration could not 
be tested. However, there is a large body of 
research that has proven endothelial cell 
movement is possible through a fibrin gel.  
Although the results from this study show 
that cellular escape and migration from a 
decellularized spinach leaf scaffold into a gel 
should allow for angiogenic activity and 
consequently the ability to print cells into the 
newly formed vasculature, there are some 
limitations to the experiments and data collected. 
The stem and leaf were not seeded with the same 
density of cells, nor were they suspended in the 
same amount of media. This was to account for 
differences in main vein sizes; however, this 
could have skewed the results of the comparison. 
Additionally, although the cellular escape from 
the scaffold was measured, due to limited 
resources, no tests were completed to measure 
the pore size or porosity of the samples. Finally, 
the live/dead assays were only run for 48 hours 
with a 1000μm gel with fibroblasts. It is possible 
that a longer time and larger gel could impact the 
cells differently. Although, it is not suspected that 
this would be the case since fibrin is a key factor 
in the wound healing process and would interact 
the cells readily [61]. Most of the experiments 
were performed with fibroblasts or human 
mesenchymal stem cells to ensure that cells 
would be able to perform these functions, but 
confirming these experiments with HUVECs 
would be most beneficial since these cells line the 
blood vessels in the body. 
VIII. CONCLUSIONS AND 
RECOMMENDATIONS 
he lack of sustainable and mechanically intact 
vasculature hinders scientists from 
engineering functional organs for transplants. 
The lack of sustainable and mechanically intact 
vasculature hinders scientists from engineering 
functional organs for transplants. The scale on 
which scientists are having trouble diffusing 
oxygen and nutrients through a tissue is 200µm 
[32]. During wound healing, the body can 
regenerate vessels over larger distances while 
maintaining oxygen rich vasculature [21]. One 
potential solution to overcome this problem is to 
mimic angiogenic functions, and apply their 
sprouting mechanisms to in vitro tissues, with the 
ultimate goal of creating vasculature to supply 
nutrients to a functional organ. 
This project is a proof of concept that cells 
can migrate from a scaffold and into a gel – 
mimicking the first stages of angiogenesis, and 
consequently, the printing of cells into this 
construct to create functioning tissue. These steps 
include cellular escape and migration from the 
original vessel. From the initial studies, it was 
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determined that the spinach leaf had better 
cellular adhesion than the parsley stem and was a 
more viable option for the final construct. These 
experiments coupled with previous research 
show the potential for cellular adhesion, escape, 
and migration from a scaffold and into a gel 
matrix. Mimicking the initial stages of 
angiogenesis would address the oxygen and 
nutrient diffusion problem engineers are facing 
when designing artificial organs. Plant scaffolds 
were treated with fibronectin and seeded with 
quantum dot loaded human mesenchymal stem 
cells showed adequate cellular adhesion 
throughout the inside of the scaffold and the 
scaffold also demonstrated adequate cellular 
escape through the walls.  
Coupling our results with previous research, 
cellular escape from a scaffold and migration 
through a gel to form a complete vascular 
network is feasible with further time and 
resources. Additionally, this shows the potential 
for the leaf scaffold must integrate itself into its 
surrounding environment. This could be applied 
to different sects of regenerative medicine, 
particularly to the mass production of 3D 
bioprinted organs. This application could be 
expanded upon and coupled with a bioreactor, to 
potentially transform the scaffold into a 
functioning organ itself, while maintaining low 
cost and long-term durability. The next step 
would be to dictate cellular movement within the 
gel. Having the ability to direct cellular 
movement from an existing scaffold would be one 
step closer to solving the vascularization problem 
associated with 3D printed organs. This could be 
competed with the use of growth factors. 
Specifically, VEGF can be used to guide cells to 
the correct regions and allow for the formation of 
blood vessels that are no more than 200µm from 
the closest cell. The next step would be to culture 
the constructs for a longer time period to allow 
the cells to mature, and form established 
vasculature. These constructs would then need to 
be tested for mechanical durability and pressure 
tolerance within the vessels. Eventually, 
following the formation of a complete vascular 
network, different cells would be printed into the 
matrix to develop functioning tissues and organs. 
Following this, in vivo studies need to be 
conducted to test the mechanical viability of these 
decellularized scaffolds or the tissues formed 
within the vasculature.  
This project shows the significance plant 
scaffolds can have on the field of regenerative 
medicine and tissue engineering. As seen in 
biocompatibility studies, cells of the host animal 
penetrated the plant scaffold and integrate 
themselves into its physiology. This 
biocompatibility allows plant scaffolds to be used 
for not only regenerative medicine, but to develop 
new functioning organs through 3D bioprinting. 
By creating a vascular network within a gel, 
scientists become one step closer to solving the 
oxygen and nutrient diffusion problem, allowing 
for the mass production of artificial organs. 
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IX. APPENDICES 
 
A. PAIRWISE ANALYSIS WITH THE PROJECT SPONSOR 
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Induce Angiogenesis  1 1 1 1 1 1 0 1 1 8 2 
Induce Vasculogenesis 0  0.5 1 1 1 1 0 1 1 6.5 3 
Connectibility 0 0.5  1 1 1 1 0 1 1 6.5 3 
Minimize Cell Death 0 0 0  1 1 1 0 1 1 5 4 
Print on/in Vasculature 0 0 0 0  0 0 0 0 0 0 9 
Time for Vascular Growth 0 0 0 0 1  0 0 1 1 3 6 
Vasculature Durability 0 0 0 0 1 1  0 1 1 4 5 
Diffusion of Nutrients 1 1 1 1 1 1 1  0 1 8 1 
Scalable/Reproducible 0 0 0 0 1 0 0 1  1 3 7 
Low Cost 0 0 0 0 1 0 0 0 0  1 8 
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